332 related articles for article (PubMed ID: 24102615)
1. In vitro-in vivo correlations for three different commercial immediate-release indapamide tablets.
Yaro P; He X; Liu W; Xun M; Ma Y; Li Z; Shi X
Drug Dev Ind Pharm; 2014 Dec; 40(12):1670-6. PubMed ID: 24102615
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous Evaluation of Dissolution and Permeation of Oral Drug Solid Formulations for Predicting Absorption Rate-Limiting Factors and In Vitro-In Vivo Correlations: Case Study Using a Poorly Soluble Weakly Basic Drug.
Li Z; He X; Tian S; Feng G; Huang C; Xun M; Wu Z; Wang Y
AAPS PharmSciTech; 2019 Oct; 20(8):321. PubMed ID: 31650430
[TBL] [Abstract][Full Text] [Related]
3. In Vitro-In Vivo Predictive Dissolution-Permeation-Absorption Dynamics of Highly Permeable Drug Extended-Release Tablets via Drug Dissolution/Absorption Simulating System and pH Alteration.
Li ZQ; Tian S; Gu H; Wu ZG; Nyagblordzro M; Feng G; He X
AAPS PharmSciTech; 2018 May; 19(4):1882-1893. PubMed ID: 29663288
[TBL] [Abstract][Full Text] [Related]
4. Study on dissolution and absorption of four dosage forms of isosorbide mononitrate: level A in vitro-in vivo correlation.
Li ZQ; He X; Gao X; Xu YY; Wang YF; Gu H; Ji RF; Sun SJ
Eur J Pharm Biopharm; 2011 Oct; 79(2):364-71. PubMed ID: 21569844
[TBL] [Abstract][Full Text] [Related]
5. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
[TBL] [Abstract][Full Text] [Related]
6. In-vitro and in-vivo correlation for two gliclazide extended-release tablets.
Mandal U; Ray KK; Gowda V; Ghosh A; Pal TK
J Pharm Pharmacol; 2007 Jul; 59(7):971-6. PubMed ID: 17637192
[TBL] [Abstract][Full Text] [Related]
7. Development of In Vitro-In Vivo Correlation for Amorphous Solid Dispersion Immediate-Release Suvorexant Tablets and Application to Clinically Relevant Dissolution Specifications and In-Process Controls.
Kesisoglou F; Hermans A; Neu C; Yee KL; Palcza J; Miller J
J Pharm Sci; 2015 Sep; 104(9):2913-22. PubMed ID: 25611455
[TBL] [Abstract][Full Text] [Related]
8. In vitro - in vivo correlation: from theory to applications.
Emami J
J Pharm Pharm Sci; 2006; 9(2):169-89. PubMed ID: 16959187
[TBL] [Abstract][Full Text] [Related]
9. Novel extended IVIVC combined with DoE to predict pharmacokinetics from formulation compositions.
Lim JY; Kim TH; Song CH; Kim DH; Shin BS; Shin S
J Control Release; 2022 Mar; 343():443-456. PubMed ID: 35124130
[TBL] [Abstract][Full Text] [Related]
10. IVIVC in oral absorption for fenofibrate immediate release tablets using a dissolution/permeation system.
Buch P; Langguth P; Kataoka M; Yamashita S
J Pharm Sci; 2009 Jun; 98(6):2001-9. PubMed ID: 18855916
[TBL] [Abstract][Full Text] [Related]
11. Application of an in vitro DDASS to evaluate oral absorption of two chemicals simultaneously: establishment of a level A in vitro-in vivo correlation.
Hou J; He X; Xu X; Shi X; Xu Y; Liu C
Drug Dev Ind Pharm; 2012 Nov; 38(11):1305-12. PubMed ID: 22296178
[TBL] [Abstract][Full Text] [Related]
12. Development of a Level A in Vitro-in Vivo Correlation for Veliparib (ABT-888) Extended Release Tablet Formulation.
Mittapalli RK; Nuthalapati S; Delke DeBord AE; Xiong H
Pharm Res; 2017 Jun; 34(6):1187-1192. PubMed ID: 28243955
[TBL] [Abstract][Full Text] [Related]
13. Development of a bionic system for the simultaneous prediction of the release/absorption characteristics of enteric-coated formulations.
Liu W; He X; Li Z; Gao X; Ma Y; Xun M; Liu C
Pharm Res; 2013 Feb; 30(2):596-605. PubMed ID: 23135820
[TBL] [Abstract][Full Text] [Related]
14. In vitro/in vivo correlations of dissolution data of carbamazepine immediate release tablets with pharmacokinetic data obtained in healthy volunteers.
Lake OA; Olling M; Barends DM
Eur J Pharm Biopharm; 1999 Jul; 48(1):13-9. PubMed ID: 10477323
[TBL] [Abstract][Full Text] [Related]
15. Predictive ability of level A in vitro-in vivo correlation for ringcap controlled-release acetaminophen tablets.
Dalton JT; Straughn AB; Dickason DA; Grandolfi GP
Pharm Res; 2001 Dec; 18(12):1729-34. PubMed ID: 11785693
[TBL] [Abstract][Full Text] [Related]
16. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
17. Extended release dosage form of glipizide: development and validation of a level A in vitro-in vivo correlation.
Ghosh A; Bhaumik UK; Bose A; Mandal U; Gowda V; Chatterjee B; Chakrabarty US; Pal TK
Biol Pharm Bull; 2008 Oct; 31(10):1946-51. PubMed ID: 18827360
[TBL] [Abstract][Full Text] [Related]
18. Development of In Vitro-In Vivo Correlation for Potassium Chloride Extended Release Tablet Formulation Using Urinary Pharmacokinetic Data.
Mittapalli RK; Marroum P; Qiu Y; Apfelbaum K; Xiong H
Pharm Res; 2017 Jul; 34(7):1527-1533. PubMed ID: 28512718
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of an in vitro-in vivo correlation for buspirone hydrochloride extended release tablets.
Takka S; Sakr A; Goldberg A
J Control Release; 2003 Feb; 88(1):147-57. PubMed ID: 12586512
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of discriminating method of dissolution for fosamprenavir tablets based on in vivo data.
Rossi RC; Dias CL; Bajerski L; Bergold AM; Fröehlich PE
J Pharm Biomed Anal; 2011 Feb; 54(3):439-44. PubMed ID: 20943342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
